Genetic engineering of T cells for adoptive immunotherapy
about
CARs in chronic lymphocytic leukemia -- ready to driveExploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinicCIG-DB: the database for human or mouse immunoglobulin and T cell receptor genes available for cancer studies.Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy.Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies.Gene therapy for cancer: present status and future perspectiveRapid cloning, expression, and functional characterization of paired αβ and γδ T-cell receptor chains from single-cell analysis.Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome.An NKp30-based chimeric antigen receptor promotes T cell effector functions and antitumor efficacy in vivoAdoptive immunotherapy: good habits instilled at youth have long-term benefits.Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function.Chimeric antibody receptors (CARs): driving T-cell specificity to enhance anti-tumor immunityDesigning customized cell signalling circuitsAllogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies.Biomarkers in T cell therapy clinical trials.Chimeric antigen receptors in cancer immuno-gene therapy: current status and future directions.Cellular immunotherapy for plasma cell myeloma.Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy.Th17 cells in cancer: the ultimate identity crisis.T-cell therapies for HIV: Preclinical successes and current clinical strategies.Micro-/nanoscale electroporation.Engineering HIV-Specific Immunity with Chimeric Antigen Receptors.Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells.Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor.Engineering scalable biological systems.ImmTACs: Novel bi-specific agents for targeted cancer therapy.CRISPRed Macrophages for Cell-Based Cancer Immunotherapy.
P2860
Q26830526-7C30B07E-4378-46AA-813E-B742F6ED2972Q28075992-7CB519A4-5668-4EBC-B7A8-960DC724EAA0Q33642275-BAE7976C-8EC0-4CC7-8748-570B72260171Q34122292-4DF32E62-2A5E-4ABD-9F62-D4B6AD237121Q34170012-E1DE36FE-91DD-4BD8-8BA0-32472D325183Q35001971-B5A598A4-72ED-41C1-AA64-28A8BA6B9D9FQ35673900-F0105959-E6F0-4CE7-9679-C52E6A3E1E63Q35917978-7CF5BC63-B1E9-47EB-84DE-E5F24D8C22B4Q35935862-575272CB-468B-4DDA-A833-99A1AAF050A6Q36787587-91F42DBD-6A55-47C2-BCC5-04FD017135DFQ37257225-A719BC27-F610-4A97-9CAE-E4BF674E153DQ37455362-0FA3A1B1-4390-46B6-B8BA-2C52F8E5B37DQ37469199-63D174B7-0F6D-417E-832D-AD49302303A7Q37756518-5C8467F1-930D-475C-875C-B9C4920B20E2Q37810098-88B3ED5A-E766-473B-81AD-998F0B58C1D7Q37919589-E0D0D02A-C2A4-4518-85F1-1796BBB8F061Q37952805-2F6D1B78-49CF-49F1-87AD-5360B98F8793Q38104288-88291C5F-5338-45AC-9C2A-B8EEF61ED377Q38214635-6FACE9A6-8BC4-47CC-8A80-4E71693D51AFQ38225542-B2924FF5-4FC8-4BA0-94D0-A2F81A9D2065Q38856090-4090A82F-A8FF-4C34-9515-D8F954555629Q38974543-B3A4A3BD-6E4E-4EE6-9028-21132A73F7C8Q39025469-8312393F-6A51-4E99-9B18-500462DB1889Q39113639-E4676BD5-D47E-4AA0-9462-4821956221CAQ41918232-9003D41B-B6E6-4468-B668-93E00B1CD3EAQ42092679-A684BFBC-EB5B-42F6-85FE-8E04F86588E1Q43225889-CFEE3A1E-2573-4477-95CC-C0E7C524DCB1Q47235117-42402727-A6DD-43AE-8A51-FEA62929289F
P2860
Genetic engineering of T cells for adoptive immunotherapy
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Genetic engineering of T cells for adoptive immunotherapy
@ast
Genetic engineering of T cells for adoptive immunotherapy
@en
Genetic engineering of T cells for adoptive immunotherapy
@nl
type
label
Genetic engineering of T cells for adoptive immunotherapy
@ast
Genetic engineering of T cells for adoptive immunotherapy
@en
Genetic engineering of T cells for adoptive immunotherapy
@nl
prefLabel
Genetic engineering of T cells for adoptive immunotherapy
@ast
Genetic engineering of T cells for adoptive immunotherapy
@en
Genetic engineering of T cells for adoptive immunotherapy
@nl
P2093
P2860
P1433
P1476
Genetic engineering of T cells for adoptive immunotherapy
@en
P2093
Angel Varela-Rohena
Angela Mexas
Carl H June
Carmine Carpenito
Elena E Perez
James L Riley
John Scholler
Max Richardson
Michael Milone
Richard G Carroll
P2860
P2888
P304
P356
10.1007/S12026-008-8057-6
P407
P577
2008-01-01T00:00:00Z
P5875
P6179
1031134227